Panel Nixes Pfizer Fraudulent Marketing MDL
The U.S. Judicial Panel on Multidistrict Litigation denied the motion for centralization on Tuesday, saying that even though the two suits shared allegations, it questioned whether the lead plaintiffs would be able to prosecute all of the claims in each complaint.
The suits, brought in the Eastern District of Pennsylvania and the District...
To view the full article, register now.